Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2V617F mutational status

被引：7
|
作者：
Ohyashiki, K. [1 ]
Akahane, D.
Gotoh, A.
Ito, Y.
Tauchi, T.
Miyazawa, K.
Kimura, Y.
Ohyashiki, J. H.
机构：
[1] Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan
[2] Tokyo Med Univ, Intractable Immune Syst Dis Res Ctr, Tokyo, Japan
来源：
LEUKEMIA | 2007年 / 21卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2404829
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2544 / 2545
页数：3
相关论文
共 50 条
  • [31] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    Tefferi, A.
    Strand, J. J.
    Lasho, T. L.
    Knudson, R. A.
    Finke, C. M.
    Gangat, N.
    Pardanani, A.
    Hanson, C. A.
    Ketterling, R. P.
    LEUKEMIA, 2007, 21 (09) : 2074 - 2075
  • [32] Early-polycythemia vera (e-PV) with thrombocytosis:: Clinical characteristics, morphological features and JAK2V617F mutational status contributing to the differential diagnosis with essential thrombocythemia.
    Iurlo, Alessandra
    Gianelli, Umberto
    Moro, Alessia
    Bianchi, Paola
    Fermo, Elisa
    Vener, Claudia
    Savi, Federica
    Franca, Radaelli
    Bosari, Silvano
    Zanella, Alberto
    BLOOD, 2006, 108 (11) : 1036A - 1037A
  • [33] Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera
    Rossi, davide
    Cortini, Francesca
    Deambrogi, Clara
    Barbieri, Caterina
    Cerri, Michaela
    Franceschetti, Silvia
    Conconi, Annarita
    Capello, Daniela
    Gaidano, Gianluca
    LEUKEMIA RESEARCH, 2007, 31 (01) : 97 - 101
  • [34] The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera
    Falchi, Mario
    Varricchio, Lilian
    Martelli, Fabrizio
    Marra, Manuela
    Picconi, Orietta
    Tafuri, Agostino
    Girelli, Gabriella
    Uversky, Vladimir N.
    Migliaccio, Anna Rita
    EXPERIMENTAL HEMATOLOGY, 2017, 50 : 53 - 76
  • [35] Identification of two novel mutations besides JAK2V617F in a patient with polycythemia vera
    Xie, X.
    Koffke-Marchant, K.
    Lichtin, A.
    Palinchik, K.
    Jakubowski, M.
    Murugesan, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05) : 670 - 670
  • [36] Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth
    Li, Zhe
    Xu, Mingjiang
    Xing, Shu
    Ho, Wanting Tina
    Ishii, Takefumi
    Li, Qingshan
    Fu, Xueqi
    Zhao, Zhizhuang Joe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) : 3428 - 3432
  • [37] JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia
    Randi, Maria Luigia
    Ruzzon, Elisabetta
    Tezza, Fabiana
    Scapin, Margherita
    Duner, Elena
    Scandellari, Raffaella
    Fabris, Fabrizio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 (01) : 17 - 21
  • [38] Leukocyte alkaline phosphatase expression predicts the JAK2V617F mutation status in polycythemia vera and essential thrombocythemia
    Guerini, V
    Carobbio, A.
    Salvi, A.
    Spinelli, O.
    Finazzi, G.
    Delaini, F.
    Barbui, T.
    Rambaldi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 125 - 125
  • [39] Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
    Swierczek, Sabina I.
    Yoon, Donghoon
    Bellanne-Chantelot, Christine
    Kim, Soo Jin
    Saint-Martin, Cecile
    Delhommeau, Francois
    Najman, Albert
    Prchal, Josef T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (05): : 775 - 778
  • [40] A JAK2V617F Variant Allele Frequency Greater Than 50% Identifies Patients with Polycythemia Vera at High Risk for Venous Thrombosis
    Loscocco, Giuseppe Gaetano
    Guglielmelli, Paola
    Mannarelli, Carmela
    Rossi, Elena
    Mannelli, Francesco
    Ramundo, Francesco
    Coltro, Giacomo
    Betti, Silvia
    Maccari, Chiara
    Ceglie, Sara
    Paoli, Chiara
    Barbui, Tiziano
    Tefferi, Ayalew
    De Stefano, Valerio
    Vannucchi, Alessandro
    BLOOD, 2021, 138
12345